FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
Jim Vititoe | July 8, 2008
Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture
The U.S. Food and Drug Administration (FDA) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary. Through its new authority under the Food and Drug Administration Amendments [...]